phenylbutazone has been researched along with Marfan Syndrome, Type I in 1 studies
Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| AGUIRRE, M | 1 |
| TORRES, JA | 1 |
| DE OYA, JC | 1 |
1 other study available for phenylbutazone and Marfan Syndrome, Type I
| Article | Year |
|---|---|
[Usefulness of phenylbutazone as a diagnostic element in Hodgkin's disease].
Topics: Arachnodactyly; Hodgkin Disease; Humans; Marfan Syndrome; Phenylbutazone | 1963 |